agilon health, inc.
AGL
$0.65
-$0.01-1.99%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.89% | -5.71% | 9.69% | -5.82% | -435.33% |
| Total Depreciation and Amortization | 23.85% | 30.86% | 73.98% | 88.19% | 208.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.17% | -82.08% | -79.13% | -45.88% | 312.50% |
| Change in Net Operating Assets | 76.48% | 513.05% | 302.36% | 1,153.25% | 241.67% |
| Cash from Operations | 49.17% | 58.52% | 70.67% | 63.01% | 6.64% |
| Capital Expenditure | 2.71% | 3.95% | -25.12% | -12.91% | -23.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 98.26% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.40% | 89.00% | 65.09% | 1,754.52% | 1,000.70% |
| Cash from Investing | -21.33% | 108.45% | 12.25% | 417.80% | 329.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 75.00% | 33.33% | 0.00% | -33.33% |
| Issuance of Common Stock | -- | -- | -- | -85.70% | -84.87% |
| Repurchase of Common Stock | 96.45% | 61.64% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.95% | -606.61% | 98.36% | 98.66% | 98.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.29% | 164.92% | 107.02% | 120.22% | 93.59% |